New CAR-T therapy aims to wipe out myeloma cells
NCT ID NCT07149857
First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times
Summary
This study tests a new cancer treatment called cilta-cel for people with multiple myeloma, a type of blood cancer. The goal is to see if a modified chemotherapy preparation can make the treatment work better and be safer. About 60 participants will receive the therapy and be monitored for at least a year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Austin Hospital
RECRUITINGHeidelberg, 3084, Australia
-
Cleveland Clinic
RECRUITINGCleveland, Ohio, 44195, United States
-
Clinica Univ. de Navarra
RECRUITINGPamplona, 31008, Spain
-
Fiona Stanley Hospital
RECRUITINGMurdoch, 6150, Australia
-
Hosp Clinico Univ de Salamanca
RECRUITINGSalamanca, 37007, Spain
-
Hosp Univ Vall D Hebron
RECRUITINGBarcelona, 08035, Spain
-
Hosp. Clinic de Barcelona
RECRUITINGBarcelona, 08036, Spain
-
Hosp. Univ. 12 de Octubre
RECRUITINGMadrid, 28041, Spain
-
Hosp. Univ. Germans Trias I Pujol
RECRUITINGBadalona, 08916, Spain
-
Hosp. Univ. Marques de Valdecilla
RECRUITINGSantander, 39008, Spain
-
Hosp. Virgen Del Rocio
RECRUITINGSeville, 41013, Spain
-
Memorial Sloan Kettering Cancer Center
ACTIVE_NOT_RECRUITINGNew York, New York, 10065, United States
-
Moffitt Cancer Center
ACTIVE_NOT_RECRUITINGTampa, Florida, 33612, United States
-
Princess Alexandra Hospital
RECRUITINGWoolloongabba, 4102, Australia
-
Royal Prince Alfred Hospital
RECRUITINGCamperdown, 2050, Australia
-
University of California San Francisco
RECRUITINGSan Francisco, California, 94143, United States
-
University of Iowa Hospital and Clinics
ACTIVE_NOT_RECRUITINGIowa City, Iowa, 52242, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact